Breast cancer genomic test could spare millions from chemotherapy

BY THE OPTIMIST DAILY EDITORIAL TEAM

For decades, high clinical risk and chemotherapy arrived together as a package deal in early breast cancer. A trial presented at the American Society of Clinical Oncology meeting in Chicago on May 30, 2026, is pulling them apart.

The OPTIMA trial enrolled…

Click here to view the original article.